Market Overview:
The global respiratory diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory diseases, growing demand for point-of-care testing, and technological advancements in respiratory diagnostics instruments and devices. In terms of type, the global respiratory diagnostics market is segmented into instruments and devices, assays and reagents, services and software. The instruments and devices segment is expected to account for the largest share of the global respiratory diagnostics market in 2018. This segment is further divided into diagnostic equipment (spirometers, peak flow meters), consumables (disposable sensors),and other equipment (nasal prongs). The diagnostic equipment segment accounted for the largest share of this subsegment in 2017 owing to its growing demand for point-of-care testing. In terms of application, the global respiratory diagnostics market is divided into hospital/clinical laboratories, physician offices, reference laboratories,,and other end users such as home care settings and long term care facilities).
Product Definition:
Respiratory diagnostics is the process of diagnosing respiratory diseases. Respiratory diseases can be caused by a variety of factors, including infections, environmental exposures, and genetic disorders. Respiratory diagnostics is important because it can help identify the cause of respiratory problems and allow for treatment to begin.
Instruments and Devices:
Instruments and devices are the key factors driving the growth of respiratory diagnostic market. Increasing prevalence of chronic respiratory diseases such as asthma, bronchitis & COPD is expected to serve this market as a high impact rendering driver. In addition, increasing demand for point-of-care testing (POCT) is also expected to fuel growth during the forecast period.
Assays and Reagents:
Respiratory diagnostic tests are used for the detection of diseases such as asthma, COPD, and other pulmonary disorders. These tests require reagents and assays which are provided by the manufacturers along with the test kits. The number of different types of respiratory disease is increasing globally due to factors such as changing climate, pollution in cities coupled with an increase in smoking population over the world.
Application Insights:
The hospital/clinical laboratories segment dominated the global respiratory diagnostics market in 2017. This can be attributed to factors such as an increase in demand for rapid, accurate, and sensitive tests for diagnosis of respiratory diseases. Furthermore, an increase in prevalence of chronic conditions such as asthma is expected to drive the segment growth over the forecast period.
Respiratory diagnostic tests are highly preferred among hospital clinical laboratories due to their high accuracy and reliability compared to other methods used for diagnosis of similar diseases or conditions. These hospitals/clinical laboratories perform a significant amount of testing on patients referred by physicians offices or emergency rooms regarding various disorders pertaining with lungs and breathing tubes called endotracheal tubes (ETT).
Regional Analysis:
North America dominated the global respiratory diagnostics market in 2017. This can be attributed to factors such as favorable reimbursement policies, high prevalence of chronic diseases, and availability of highly skilled physicians. Moreover, increasing demand for point-of-care (PoC) diagnostic devices is expected to drive the regional market during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising healthcare expenditure and improving healthcare infrastructure in emerging countries such as China and India.
Major players operating in this industry include Abbott; Bio-Rad Laboratories; CELGENE CORP.; EMD Millipore; GE Healthcare; Hologic Inc.; Merck KGaA Darmstadt GmbH & Co., Ltd.; Roche Diagnostics Corporation; Siemens Healthineers AG & Co., Ltd.
Growth Factors:
- Increasing incidence of respiratory diseases: The global respiratory diagnostics market is expected to grow at a CAGR of 7.5% from 2016 to 2021, owing to the increasing incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
- Technological advancements: The development of novel technologies for the diagnosis and treatment of respiratory diseases is expected to drive the growth of the global respiratory diagnostics market.
- Rising demand for point-of-care testing: The demand for point-of-care testing is increasing due to its advantages over traditional laboratory tests such as faster turnaround time and lower costs. This is expected to boost the growth of the global respiratory diagnostics market during the forecast period.
- Growing awareness about early diagnosis and treatment: There is an increasing awareness among people about early diagnosis and treatment options for various types of respiratory diseases, which is likely to propel the growth ofthe globalrespiratorydiagnosticsmarket in coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Diagnostics Market Research Report
By Type
Instruments and Devices, Assays and Reagents, Services and Software
By Application
Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users
By Companies
Philips Healthcare, Becton, Dickinson, Abbott Laboratories, Thermo Fisher Scientific, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Diagnostics Market Report Segments:
The global Respiratory Diagnostics market is segmented on the basis of:
Types
Instruments and Devices, Assays and Reagents, Services and Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips Healthcare
- Becton, Dickinson
- Abbott Laboratories
- Thermo Fisher Scientific
- Abbott
Highlights of The Respiratory Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments and Devices
- Assays and Reagents
- Services and Software
- By Application:
- Hospital/Clinical Laboratories
- Physician Offices
- Reference Laboratories
- Other End Users
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory diagnostics is a field of medicine that uses diagnostic tests to identify and diagnose respiratory problems. These tests can include chest x-rays, spirometry (measuring how much air a person can breathe in and out), and blood tests.
Some of the major companies in the respiratory diagnostics market are Philips Healthcare, Becton, Dickinson, Abbott Laboratories, Thermo Fisher Scientific, Abbott.
The respiratory diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Diagnostics Market Size & Forecast, 2020-2028
4.5.1 Respiratory Diagnostics Market Size and Y-o-Y Growth
4.5.2 Respiratory Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Instruments and Devices
5.2.2 Assays and Reagents
5.2.3 Services and Software
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital/Clinical Laboratories
6.2.2 Physician Offices
6.2.3 Reference Laboratories
6.2.4 Other End Users
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Instruments and Devices
9.6.2 Assays and Reagents
9.6.3 Services and Software
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital/Clinical Laboratories
9.10.2 Physician Offices
9.10.3 Reference Laboratories
9.10.4 Other End Users
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Instruments and Devices
10.6.2 Assays and Reagents
10.6.3 Services and Software
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital/Clinical Laboratories
10.10.2 Physician Offices
10.10.3 Reference Laboratories
10.10.4 Other End Users
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Instruments and Devices
11.6.2 Assays and Reagents
11.6.3 Services and Software
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital/Clinical Laboratories
11.10.2 Physician Offices
11.10.3 Reference Laboratories
11.10.4 Other End Users
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Instruments and Devices
12.6.2 Assays and Reagents
12.6.3 Services and Software
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital/Clinical Laboratories
12.10.2 Physician Offices
12.10.3 Reference Laboratories
12.10.4 Other End Users
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Instruments and Devices
13.6.2 Assays and Reagents
13.6.3 Services and Software
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital/Clinical Laboratories
13.10.2 Physician Offices
13.10.3 Reference Laboratories
13.10.4 Other End Users
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Diagnostics Market: Competitive Dashboard
14.2 Global Respiratory Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Philips Healthcare
14.3.2 Becton, Dickinson
14.3.3 Abbott Laboratories
14.3.4 Thermo Fisher Scientific
14.3.5 Abbott
